Is combination of buccal plus palatal injection better than the buccal alone during the endodontic treatment of maxillary molars using 2% lidocaine and 4articaine with same adrenaline concentration- A clinical study

Not Applicable

• Registration Number: CTRI/2021/05/033659
• Lead Sponsor: Department of Oral Health Science Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

The inclusion criteria for the study were as follows: moderate to severe pain in the maxillary first molar, a prolonged response to cold testing with an ice stick and an electric pulp tester (Kerr Pulp Tester; Analytic Technology Corp, Redmond, WA), the absence of any periapical radiolucency on radiographs except for a widened periodontal ligament, a vital coronal pulp on access opening, and the ability of the subject to understand the use of pain scales. The subjects were in good health, and none were taking any medication that would alter pain perception, as determined by oral questioning and a written questionnaire.

Exclusion Criteria

The exclusion criteria for the study were as follows: subjects younger than 18 years of age or older than 50 years of age, any known sensitivity to either 2% lidocaine or 4% articaine or epinephrine, patients having active pain in more than 1 maxillary molar, subject taking any pain-relieving medication including over-the-counter analgesics at least 12 hours before enrollment in the study, and swelling near the tooth in question and having a tooth not suitable for simple restorative treatment because of extensive caries or periodontal problems.

Study & Design

• Study Type: Interventional
• Study Design: Not specified